Ralf Gilsbach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ralf Gilsbach has a total of 550 co-authors. Here are the top co-authors by number of shared publications:
- Lutz Hein
University of Freiburg
27 shared publications Lutz Hein
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany
18 shared publications- Achim Lother
University of Freiburg
9 shared publications Sebastian Preissl
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, 79104, Freiburg, Germany
9 shared publications- Björn Grüning
University of Freiburg
8 shared publications Markus Krane
Technical University Technical University of Munich
7 shared publications
Latest Publications
- Open Access
- 12 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 117
Chamber-specific chromatin architecture guides functional interpretation of disease-associated Cis-regulatory elements in human cardiomyocytes
Cis- regulatory elements (CREs) are noncoding DNA regions regulating cell-type-specific gene expression programs by interacting with distal gene promoters. Here, we aim to decode the function and spatial organization of CRE-promoter interactions in human cardiomyocytes. We analyzed the epigenome and chromatin interactions of human male atrial, ventricular, and failing cardiomyocytes. Atrial and ventricular cardiomyocytes harbored chamber-specific CRE-promoter interactions modulating gene expression as confirmed by functional epigenetic silencing. These CRE-promoter interactions explain the distinct contribution of non-coding genetic variants to atrial and ventricular diseases, such as dilated cardiomyopathy and arrhythmias. We dissected the prototypic KCNJ2 locus, encoding a potassium channel associated with ventricular arrhythmia susceptibility. Functional epigenetic silencing confirmed that CREs, harboring QT-duration-associated genetic risk factors, modulate KCNJ2 gene expression levels, alter KCNJ2-dependent channel currents, and affect cardiomyocyte repolarization. The presented human CM-specific chromatin interaction analysis provides key insights into regulatory mechanisms and aids in interpreting genetic risk factors.
- 12 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 117
Open AccessChamber-specific chromatin architecture guides functional interpretation of disease-associated Cis-regulatory elements in human cardiomyocytes
Cis- regulatory elements (CREs) are noncoding DNA regions regulating cell-type-specific gene expression programs by interacting with distal gene promoters. Here, we aim to decode the function and spatial organization of CRE-promoter interactions in human cardiomyocytes. We analyzed the epigenome and chromatin interactions of human male atrial, ventricular, and failing cardiomyocytes. Atrial and ventricular cardiomyocytes harbored chamber-specific CRE-promoter interactions modulating gene expression as confirmed by functional epigenetic silencing. These CRE-promoter interactions explain the distinct contribution of non-coding genetic variants to atrial and ventricular diseases, such as dilated cardiomyopathy and arrhythmias. We dissected the prototypic KCNJ2 locus, encoding a potassium channel associated with ventricular arrhythmia susceptibility. Functional epigenetic silencing confirmed that CREs, harboring QT-duration-associated genetic risk factors, modulate KCNJ2 gene expression levels, alter KCNJ2-dependent channel currents, and affect cardiomyocyte repolarization. The presented human CM-specific chromatin interaction analysis provides key insights into regulatory mechanisms and aids in interpreting genetic risk factors.
- 2 January 2026
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 23 (5) , 346-362
Cardiac epigenome in heart development and disease
Genetic and acquired forms of heart disease are leading causes of death worldwide. The epigenome, which governs cellular identity by modulating the accessibility of genetic regulatory elements, is established during development by transcription factors and has a pivotal role in the execution of cellular programmes. The epigenetic layers include DNA methylation, histone modifications and chromatin accessibility, which are dynamically regulated during development and in response to stress. Advances in single-cell and cell type-resolved epigenome analyses have provided unprecedented insights into the heterocellular nature of organs such as the heart, via the identification of epigenetic mechanisms and disease-associated epigenetic alterations in cardiomyocytes and other cardiac cell types. Chromatin remodelling, driven by specific modifiers, transcription factors and chaperones, orchestrates cardiac gene expression and contributes to disease manifestation and progression. Understanding how to modulate these epigenetic pathways in a cell type-specific manner offers promising avenues for therapeutic intervention, including epigenome editing for targeted modulation of regulatory elements. In this Review, we highlight studies decoding the various layers of the cardiac epigenome, emphasizing the interplay between cell type-specific mechanisms, describe emerging methods to study the cardiac epigenome, and discuss the translational potential of targeting epigenetic mechanisms for the prevention and treatment of cardiac diseases.
- 2 January 2026
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 23 (5) , 346-362
Cardiac epigenome in heart development and disease
Genetic and acquired forms of heart disease are leading causes of death worldwide. The epigenome, which governs cellular identity by modulating the accessibility of genetic regulatory elements, is established during development by transcription factors and has a pivotal role in the execution of cellular programmes. The epigenetic layers include DNA methylation, histone modifications and chromatin accessibility, which are dynamically regulated during development and in response to stress. Advances in single-cell and cell type-resolved epigenome analyses have provided unprecedented insights into the heterocellular nature of organs such as the heart, via the identification of epigenetic mechanisms and disease-associated epigenetic alterations in cardiomyocytes and other cardiac cell types. Chromatin remodelling, driven by specific modifiers, transcription factors and chaperones, orchestrates cardiac gene expression and contributes to disease manifestation and progression. Understanding how to modulate these epigenetic pathways in a cell type-specific manner offers promising avenues for therapeutic intervention, including epigenome editing for targeted modulation of regulatory elements. In this Review, we highlight studies decoding the various layers of the cardiac epigenome, emphasizing the interplay between cell type-specific mechanisms, describe emerging methods to study the cardiac epigenome, and discuss the translational potential of targeting epigenetic mechanisms for the prevention and treatment of cardiac diseases.
- Open Access
- 10 June 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (6) , 705
Prolonged In Vivo Chemogenetic Generation of Hydrogen Peroxide by Endothelial Cells Induces Cardiac Remodelling and Vascular Dysfunction
Increased levels of reactive oxygen species (ROS) are a hallmark of cardiovascular disease. ROS impact the function of proteins largely through thiol modification leading to redox signalling. Acute, targeted interference with local ROS levels has been difficult. Therefore, how dynamics in redox signalling impact cardiovascular health is still a matter of current research. An inducible, endothelial cell-specific knock-in mouse model expressing a yeast D-amino acid oxidase enzyme was generated (Hipp11-Flox-Stop-Flox-yDAO-Cdh5-CreERT2+/0 referred to as ecDAO). DAO releases H2O2 as a by-product of the conversion of D-amino acids into imino acids. The D-amino acid treatment of DAO-expressing cells therefore increases their intracellular H2O2 production. The induction of yDAO in the ecDAO mice was performed with tamoxifen. Subsequently, the mice received D-Alanine (D-Ala, 0.5 M) through drinking water, and the effects on ROS production and vascular and cardiac function were determined. ecDAO induction increased endothelial ROS production as well as ROS production in the lung, which is rich in endothelial cells. The functional consequences of this were, however limited: After minimally invasive myocardial infarction, there was no difference in the outcome between the control (CTL) and ecDAO mice. With respect to vascular function, three days of D-Ala slightly improved vascular function as demonstrated by an increase in the diameter of the carotid artery in vivo and decreased vessel constriction to phenylephrine. Fifty-two days of D-Ala induced cardiac remodelling, increased peripheral resistance, and overoxidation of peroxiredoxins. In conclusion, acute stimulation of endothelial ROS improves cardiovascular function, whereas prolonged ROS exposure deteriorates it.
- 10 June 2025
- Published by MDPI AG in Antioxidants
- Vol. 14 (6) , 705
Open AccessProlonged In Vivo Chemogenetic Generation of Hydrogen Peroxide by Endothelial Cells Induces Cardiac Remodelling and Vascular Dysfunction
Increased levels of reactive oxygen species (ROS) are a hallmark of cardiovascular disease. ROS impact the function of proteins largely through thiol modification leading to redox signalling. Acute, targeted interference with local ROS levels has been difficult. Therefore, how dynamics in redox signalling impact cardiovascular health is still a matter of current research. An inducible, endothelial cell-specific knock-in mouse model expressing a yeast D-amino acid oxidase enzyme was generated (Hipp11-Flox-Stop-Flox-yDAO-Cdh5-CreERT2+/0 referred to as ecDAO). DAO releases H2O2 as a by-product of the conversion of D-amino acids into imino acids. The D-amino acid treatment of DAO-expressing cells therefore increases their intracellular H2O2 production. The induction of yDAO in the ecDAO mice was performed with tamoxifen. Subsequently, the mice received D-Alanine (D-Ala, 0.5 M) through drinking water, and the effects on ROS production and vascular and cardiac function were determined. ecDAO induction increased endothelial ROS production as well as ROS production in the lung, which is rich in endothelial cells. The functional consequences of this were, however limited: After minimally invasive myocardial infarction, there was no difference in the outcome between the control (CTL) and ecDAO mice. With respect to vascular function, three days of D-Ala slightly improved vascular function as demonstrated by an increase in the diameter of the carotid artery in vivo and decreased vessel constriction to phenylephrine. Fifty-two days of D-Ala induced cardiac remodelling, increased peripheral resistance, and overoxidation of peroxiredoxins. In conclusion, acute stimulation of endothelial ROS improves cardiovascular function, whereas prolonged ROS exposure deteriorates it.
- Open Access
- 5 June 2025
- Published by Taylor & Francis in Epigenetics
- Vol. 20 (1) , 2506625
Transcriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
Fibrosis, cardiac remodelling, and inflammation are hallmarks of heart failure. To date, there is no available pharmacological cure for heart failure, but mechanical unloading by implantation of a left ventricular assist device (LVAD) can lead to improved cardiac function in a subset of patients. This study aimed to identify the transcriptional response of left ventricular (LV) cardiac myocytes to mechanical unloading in a mouse model of reversible LV pressure overload and in failing human hearts after LVAD implantation. We found that partial recovery of ventricular dysfunction, LV hypertrophy, and gene expression programmes occurred in mice under reversible transverse aortic constriction (rTAC). Gene expression analysis in cardiac myocytes identified a lasting repression of mitochondrial gene expression resulting in compromised fatty acid oxidation in the mouse model of reversible pressure overload and in human LV samples after LVAD therapy and a persistent upregulation of epigenetic and transcriptional regulators. These findings underpin that recovery from heart failure involves complex gene regulatory networks and that mitochondrial dysfunction remains a challenge even after mechanical unloading. Further studies are needed to investigate the functional role of these factors in reverse remodelling and recovery of failing hearts.
- 5 June 2025
- Published by Taylor & Francis in Epigenetics
- Vol. 20 (1) , 2506625
Open AccessTranscriptional signature of cardiac myocyte recovery in mice and human reveals persistent upregulation of epigenetic factors
Fibrosis, cardiac remodelling, and inflammation are hallmarks of heart failure. To date, there is no available pharmacological cure for heart failure, but mechanical unloading by implantation of a left ventricular assist device (LVAD) can lead to improved cardiac function in a subset of patients. This study aimed to identify the transcriptional response of left ventricular (LV) cardiac myocytes to mechanical unloading in a mouse model of reversible LV pressure overload and in failing human hearts after LVAD implantation. We found that partial recovery of ventricular dysfunction, LV hypertrophy, and gene expression programmes occurred in mice under reversible transverse aortic constriction (rTAC). Gene expression analysis in cardiac myocytes identified a lasting repression of mitochondrial gene expression resulting in compromised fatty acid oxidation in the mouse model of reversible pressure overload and in human LV samples after LVAD therapy and a persistent upregulation of epigenetic and transcriptional regulators. These findings underpin that recovery from heart failure involves complex gene regulatory networks and that mitochondrial dysfunction remains a challenge even after mechanical unloading. Further studies are needed to investigate the functional role of these factors in reverse remodelling and recovery of failing hearts.
- Open Access
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Long non-coding RNAs direct the SWI/SNF complex to cell type-specific enhancers
The coordination of chromatin remodeling is essential for DNA accessibility and gene expression control. The highly conserved and ubiquitously expressed SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex plays a central role in cell type- and context-dependent gene expression. Despite the absence of a defined DNA recognition motif, SWI/SNF binds lineage specific enhancers genome-wide where it actively maintains open chromatin state. It does so while retaining the ability to respond dynamically to cellular signals. However, the mechanisms that guide SWI/SNF to specific genomic targets have remained elusive. Here we demonstrate that trans-acting long non-coding RNAs (lncRNAs) direct the SWI/SNF complex to cell type-specific enhancers. SWI/SNF preferentially binds lncRNAs and these predominantly bind DNA targets in trans. Together they localize to enhancers, many of which are cell type-specific. Knockdown of SWI/SNF- and enhancer-bound lncRNAs causes the genome-wide redistribution of SWI/SNF away from enhancers and a concomitant differential expression of spatially connected target genes. These lncRNA-SWI/SNF-enhancer networks support an enhancer hub model of SWI/SNF genomic targeting. Our findings reveal that lncRNAs competitively recruit SWI/SNF, providing a specific and dynamic layer of control over chromatin accessibility, and reinforcing their role in mediating enhancer activity and gene expression.
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessLong non-coding RNAs direct the SWI/SNF complex to cell type-specific enhancers
The coordination of chromatin remodeling is essential for DNA accessibility and gene expression control. The highly conserved and ubiquitously expressed SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex plays a central role in cell type- and context-dependent gene expression. Despite the absence of a defined DNA recognition motif, SWI/SNF binds lineage specific enhancers genome-wide where it actively maintains open chromatin state. It does so while retaining the ability to respond dynamically to cellular signals. However, the mechanisms that guide SWI/SNF to specific genomic targets have remained elusive. Here we demonstrate that trans-acting long non-coding RNAs (lncRNAs) direct the SWI/SNF complex to cell type-specific enhancers. SWI/SNF preferentially binds lncRNAs and these predominantly bind DNA targets in trans. Together they localize to enhancers, many of which are cell type-specific. Knockdown of SWI/SNF- and enhancer-bound lncRNAs causes the genome-wide redistribution of SWI/SNF away from enhancers and a concomitant differential expression of spatially connected target genes. These lncRNA-SWI/SNF-enhancer networks support an enhancer hub model of SWI/SNF genomic targeting. Our findings reveal that lncRNAs competitively recruit SWI/SNF, providing a specific and dynamic layer of control over chromatin accessibility, and reinforcing their role in mediating enhancer activity and gene expression.
- Open Access
- 11 September 2024
- Published by Springer Nature in Research Square
Linking Chamber-Specific Spatial Chromatin Interactions to Disease Variants and Gene Programs in Human Cardiomyocytes
Cell-type specific gene expression programs and response to stimuli are modulated by cis-regulatory elements (CREs). CREs modulate the activity of spatially interacting gene promoters. Heart disease is a major cause of death worldwide. Here, we aim to decode CRE-promoter interactions in atrial and ventricular cardiomyocytes and link them to heart disease and genetic risk factors. Therefore, we analyze the epigenetic features and chromatin interactions of human atrial, ventricular, and failing cardiomyocytes (CM). In failing CM a limited number of genes, including NPPA, showed rewiring events orchestrating differential gene expression. Remarkably, we find that atrial and ventricular CM harbor chamber-specific chromatin interactions which are linked to gene expression indicating that chromatin organization underlies atrial and ventricular CM specification. The chamber-specific chromatin interactions also explain the contribution of non-coding genetic CRE variants to the occurrence of atrial and ventricular diseases, including atrial and ventricular arrhythmia. Functional silencing of CREs carrying genetic QT-duration risk factors confirmed their functional relevance. Our human CM data demonstrates that cell type-specific chromatin interaction analysis provides crucial insights into regulatory mechanisms and aids the interpretation of genetic risk factors identified in patients and association studies.
- 11 September 2024
- Published by Springer Nature in Research Square
Open AccessLinking Chamber-Specific Spatial Chromatin Interactions to Disease Variants and Gene Programs in Human Cardiomyocytes
Cell-type specific gene expression programs and response to stimuli are modulated by cis-regulatory elements (CREs). CREs modulate the activity of spatially interacting gene promoters. Heart disease is a major cause of death worldwide. Here, we aim to decode CRE-promoter interactions in atrial and ventricular cardiomyocytes and link them to heart disease and genetic risk factors. Therefore, we analyze the epigenetic features and chromatin interactions of human atrial, ventricular, and failing cardiomyocytes (CM). In failing CM a limited number of genes, including NPPA, showed rewiring events orchestrating differential gene expression. Remarkably, we find that atrial and ventricular CM harbor chamber-specific chromatin interactions which are linked to gene expression indicating that chromatin organization underlies atrial and ventricular CM specification. The chamber-specific chromatin interactions also explain the contribution of non-coding genetic CRE variants to the occurrence of atrial and ventricular diseases, including atrial and ventricular arrhythmia. Functional silencing of CREs carrying genetic QT-duration risk factors confirmed their functional relevance. Our human CM data demonstrates that cell type-specific chromatin interaction analysis provides crucial insights into regulatory mechanisms and aids the interpretation of genetic risk factors identified in patients and association studies.
- Open Access
- 10 September 2024
- Published by Springer Nature in Research Square
Linking Chamber-Specific Spatial Chromatin Interactions to Disease Variants and Gene Programs in Human Cardiomyocytes
Cell-type specific gene expression programs and response to stimuli are modulated by cis-regulatory elements (CREs). CREs modulate the activity of spatially interacting gene promoters. Heart disease is a major cause of death worldwide. Here, we aim to decode CRE-promoter interactions in atrial and ventricular cardiomyocytes and link them to heart disease and genetic risk factors. Therefore, we analyze the epigenetic features and chromatin interactions of human atrial, ventricular, and failing cardiomyocytes (CM). In failing CM a limited number of genes, including NPPA, showed rewiring events orchestrating differential gene expression. Remarkably, we find that atrial and ventricular CM harbor chamber-specific chromatin interactions which are linked to gene expression indicating that chromatin organization underlies atrial and ventricular CM specification. The chamber-specific chromatin interactions also explain the contribution of non-coding genetic CRE variants to the occurrence of atrial and ventricular diseases, including atrial and ventricular arrhythmia. Functional silencing of CREs carrying genetic QT-duration risk factors confirmed their functional relevance. Our human CM data demonstrates that cell type-specific chromatin interaction analysis provides crucial insights into regulatory mechanisms and aids the interpretation of genetic risk factors identified in patients and association studies.
- 10 September 2024
- Published by Springer Nature in Research Square
Open AccessLinking Chamber-Specific Spatial Chromatin Interactions to Disease Variants and Gene Programs in Human Cardiomyocytes
Cell-type specific gene expression programs and response to stimuli are modulated by cis-regulatory elements (CREs). CREs modulate the activity of spatially interacting gene promoters. Heart disease is a major cause of death worldwide. Here, we aim to decode CRE-promoter interactions in atrial and ventricular cardiomyocytes and link them to heart disease and genetic risk factors. Therefore, we analyze the epigenetic features and chromatin interactions of human atrial, ventricular, and failing cardiomyocytes (CM). In failing CM a limited number of genes, including NPPA, showed rewiring events orchestrating differential gene expression. Remarkably, we find that atrial and ventricular CM harbor chamber-specific chromatin interactions which are linked to gene expression indicating that chromatin organization underlies atrial and ventricular CM specification. The chamber-specific chromatin interactions also explain the contribution of non-coding genetic CRE variants to the occurrence of atrial and ventricular diseases, including atrial and ventricular arrhythmia. Functional silencing of CREs carrying genetic QT-duration risk factors confirmed their functional relevance. Our human CM data demonstrates that cell type-specific chromatin interaction analysis provides crucial insights into regulatory mechanisms and aids the interpretation of genetic risk factors identified in patients and association studies.
- 1 September 2024
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 327 (3) , H573-H581
Gene expression networks in endothelial cells from failing human hearts
Gene coexpression network analysis defined 26 gene clusters expressed in endothelial cells from failing human hearts. Transcription factors CASZ1, ZNF523, and NFE2L1 were identified as hub genes of a cluster related to angiogenesis. Knockdown of CASZ1, ZNF523, or NFE2L1 in human umbilical vein endothelial cells led to a downregulation of genes from the respective cluster, confirming their regulatory function. This provides insights into the transcriptional regulation of angiogenesis in heart failure beyond classical signaling pathways.
- 1 September 2024
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 327 (3) , H573-H581
Gene expression networks in endothelial cells from failing human hearts
Gene coexpression network analysis defined 26 gene clusters expressed in endothelial cells from failing human hearts. Transcription factors CASZ1, ZNF523, and NFE2L1 were identified as hub genes of a cluster related to angiogenesis. Knockdown of CASZ1, ZNF523, or NFE2L1 in human umbilical vein endothelial cells led to a downregulation of genes from the respective cluster, confirming their regulatory function. This provides insights into the transcriptional regulation of angiogenesis in heart failure beyond classical signaling pathways.
- Open Access
Long non-coding RNAs direct the SWI/SNF complex to cell-specific enhancers
The coordination of chromatin remodeling is essential for DNA accessibility and gene expression control 1 . The highly conserved and ubiquitously expressed SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex plays a central role in cell type- and context-dependent gene expression 2 . Despite the absence of a defined DNA recognition motif, SWI/SNF binds lineage specific enhancers genome-wide where it actively maintains open chromatin state 2–5 . It does so while retaining the ability to respond dynamically to cellular signals 4 . However, the mechanisms that guide SWI/SNF to specific genomic targets have remained elusive. Here we demonstrate that trans -acting long non-coding RNAs (lncRNAs) direct the SWI/SNF complex to cell type-specific enhancers. SWI/SNF preferentially binds lncRNAs and these predominantly bind DNA targets in trans . Together they localize to enhancers, many of which are cell type-specific. Knockdown of SWI/SNF- and enhancer-bound lncRNAs causes the genome-wide redistribution of SWI/SNF away from enhancers and a concomitant differential expression of spatially connected target genes. These lncRNA-SWI/SNF-enhancer networks support an enhancer hub model of SWI/SNF genomic targeting. Our findings reveal a competitive recruitment of SWI/SNF by lncRNAs which provide a specific and dynamic layer of control in chromatin accessibility and gene expression.
Open AccessLong non-coding RNAs direct the SWI/SNF complex to cell-specific enhancers
The coordination of chromatin remodeling is essential for DNA accessibility and gene expression control 1 . The highly conserved and ubiquitously expressed SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex plays a central role in cell type- and context-dependent gene expression 2 . Despite the absence of a defined DNA recognition motif, SWI/SNF binds lineage specific enhancers genome-wide where it actively maintains open chromatin state 2–5 . It does so while retaining the ability to respond dynamically to cellular signals 4 . However, the mechanisms that guide SWI/SNF to specific genomic targets have remained elusive. Here we demonstrate that trans -acting long non-coding RNAs (lncRNAs) direct the SWI/SNF complex to cell type-specific enhancers. SWI/SNF preferentially binds lncRNAs and these predominantly bind DNA targets in trans . Together they localize to enhancers, many of which are cell type-specific. Knockdown of SWI/SNF- and enhancer-bound lncRNAs causes the genome-wide redistribution of SWI/SNF away from enhancers and a concomitant differential expression of spatially connected target genes. These lncRNA-SWI/SNF-enhancer networks support an enhancer hub model of SWI/SNF genomic targeting. Our findings reveal a competitive recruitment of SWI/SNF by lncRNAs which provide a specific and dynamic layer of control in chromatin accessibility and gene expression.
- Open Access
- 8 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (10) , eadj5101
Atlas of cardiac endothelial cell enhancer elements linking the mineralocorticoid receptor to pathological gene expression
Endothelial cells play crucial roles in physiology and are increasingly recognized as therapeutic targets in cardiovascular disease. Here, we analyzed the regulatory landscape of cardiac endothelial cells by assessing chromatin accessibility, histone modifications, and 3D chromatin organization and confirmed the functional relevance of enhancer-promoter interactions by CRISPRi-mediated enhancer silencing. We used this dataset to explore mechanisms of transcriptional regulation in cardiovascular disease and compared six different experimental models of heart failure, hypertension, or diabetes. Enhancers that regulate gene expression in diseased endothelial cells were enriched with binding sites for a distinct set of transcription factors, including the mineralocorticoid receptor (MR), a known drug target in heart failure and hypertension. For proof of concept, we applied endothelial cell–specific MR deletion in mice to confirm MR-dependent gene expression and predicted direct MR target genes. Overall, we have compiled here a comprehensive atlas of cardiac endothelial cell enhancer elements that provides insight into the role of transcription factors in cardiovascular disease.
- 8 March 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (10) , eadj5101
Open AccessAtlas of cardiac endothelial cell enhancer elements linking the mineralocorticoid receptor to pathological gene expression
Endothelial cells play crucial roles in physiology and are increasingly recognized as therapeutic targets in cardiovascular disease. Here, we analyzed the regulatory landscape of cardiac endothelial cells by assessing chromatin accessibility, histone modifications, and 3D chromatin organization and confirmed the functional relevance of enhancer-promoter interactions by CRISPRi-mediated enhancer silencing. We used this dataset to explore mechanisms of transcriptional regulation in cardiovascular disease and compared six different experimental models of heart failure, hypertension, or diabetes. Enhancers that regulate gene expression in diseased endothelial cells were enriched with binding sites for a distinct set of transcription factors, including the mineralocorticoid receptor (MR), a known drug target in heart failure and hypertension. For proof of concept, we applied endothelial cell–specific MR deletion in mice to confirm MR-dependent gene expression and predicted direct MR target genes. Overall, we have compiled here a comprehensive atlas of cardiac endothelial cell enhancer elements that provides insight into the role of transcription factors in cardiovascular disease.